4//SEC Filing
KROLL MARK W 4
Accession 0001127602-21-018310
CIK 0000313143other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:09 PM ET
Size
8.2 KB
Accession
0001127602-21-018310
Insider Transaction Report
Form 4
KROLL MARK W
Director
Transactions
- Exercise/Conversion
Common Stock
2021-05-26$35.50/sh+10,353$367,557→ 30,253 total - Sale
Common Stock
2021-05-26$55.10/sh−11,813$650,896→ 18,440 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2021-05-26−10,353→ 0 totalExercise: $35.50From: 2015-07-24Exp: 2021-07-23→ Common Stock (10,353 underlying)
Footnotes (3)
- [F1]The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
- [F2]This number includes unvested restricted stock units previously reported.
- [F3]Option vests 100% on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001259254
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:09 PM ET
- Size
- 8.2 KB